Evidence map›Paper›PMID 39319286›Full record

ArticleInfectious Disease Modelling2025

Assessing the impact of disease incidence and immunization on the resilience of complex networks during epidemics.

M D Shahidul Islam, Mohammad Sharif Ullah, K M Ariful Kabir

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M D Shahidul IslamDepartment of Computer Science and Engineering, Green University of Bangladesh, Dhaka, Bangladesh.
Mohammad Sharif UllahDepartment of Mathematics, Feni University, Feni, Bangladesh.
K M Ariful KabirDepartment of Mathematics, Bangladesh University of Engineering and Technology, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease severity through an immunized population ensconced on a physical network topology is a key technique for preventing epidemic spreading. Its influence can be quantified by adjusting the common (basic) methodology for analyzing the percolation and connectivity of contact networks. Stochastic spreading properties are difficult to express, and physical networks significantly influence them. Visualizing physical networks is crucial for studying and intervening in disease transmission. The multi-agent simulation method is useful for measuring randomness, and this study explores stochastic characteristics of epidemic transmission in various homogeneous and heterogeneous networks. This work thoroughly explores stochastic characteristics of epidemic propagation in homogeneous and heterogeneous networks through extensive theoretical analysis (positivity and boundedness of solutions, disease-free equilibrium point, basic reproduction number, endemic equilibrium point, stability analysis) and multi-agent simulation approach using the Gilespie algorithm. Results show that Ring and Lattice networks have small stochastic variations in the ultimate epidemic size, while BA-SF networks have disease transmission starting before the threshold value. The theoretical and deterministic aftermaths strongly agree with multi-agent simulations (MAS) and could shed light on various multi-dynamic spreading process applications. The study also proposes a novel concept of void nodes, Empty nodes and disease severity, which reduces the incidence of contagious diseases through immunization and topologies.

Indexed as

Degree distributionDisease severityImmunizationNetworks

Identifiers

PMID39319286
PMCPMC11419816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.